Human Papillomavirus DNA Testing Using Self-collected Samples for Cervical Cancer Screening: an Alternative Strategy for Unscreened Women?
Phase 3
20 Years
65 Years
20 Years
65 Years
Not Enrolling
Female
Uterine Cervical Neoplasms, Uterine Cervical Dysplasia
Female
Uterine Cervical Neoplasms, Uterine Cervical Dysplasia
Trial Information
Human Papillomavirus DNA Testing Using Self-collected Samples for Cervical Cancer Screening: an Alternative Strategy for Unscreened Women?
Inclusion Criteria:
- Women between 20 and 65
Exclusion Criteria:
- Menstruation
- pregnant
- Inability to give informed consent
- Vaccinated against HPV 16 and 18
- Total Hysterectomy
- treatment of CIN 1, 2 or 3
- Abnormal smear in the past year
- Smear in the past 2 years
- Virgin
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Diagnostic
Outcome Measure:
Concordance between the three HPV tests
Outcome Time Frame:
End of the study
Safety Issue:
No
Principal Investigator
Ken HAGUENOER
Investigator Role:
Study Director
Investigator Affiliation:
François Rabelais University, Public Health Laboratory, Tours, France
Authority:
France: Ministry of Health
Study ID:
INCA08-KH/APACHE-1
NCT ID:
NCT01014026
Start Date:
September 2009
Completion Date:
March 2011
Related Keywords:
- Uterine Cervical Neoplasms
- Uterine Cervical Dysplasia
- Mass Screening
- Polymerase Chain Reaction
- Vaginal Smears
- Neoplasms
- Uterine Cervical Neoplasms
- Uterine Cervical Dysplasia
- Cervical Intraepithelial Neoplasia
Name | Location |
|---|
